Evgen Pharma plc announced a private placement for the gross proceeds of $17,400,000 on January 16, 2024. The transaction included participation from new investor Stalicla SA.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 GBX | 0.00% | 0.00% | -53.12% |
04-26 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
04-26 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.12% | 4.01M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- EVG Stock
- News Theracryf Plc
- Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA